186 related articles for article (PubMed ID: 30765454)
1. Dopamine agonist-responsive Cushing's disease.
Anand G; Bink A; Beuschlein F; Schmid C
BMJ Case Rep; 2019 Feb; 12(2):. PubMed ID: 30765454
[TBL] [Abstract][Full Text] [Related]
2. Repeated remissions of Cushing's disease due to recurrent infarctions of an ACTH-producing pituitary macroadenoma.
Alarifi A; Alzahrani AS; Salam SA; Ahmed M; Kanaan I
Pituitary; 2005; 8(2):81-7. PubMed ID: 16195779
[TBL] [Abstract][Full Text] [Related]
3. Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma.
Miyoshi T; Otsuka F; Takeda M; Inagaki K; Suzuki J; Ogura T; Date I; Hashimoto K; Makino H
J Endocrinol Invest; 2004 Dec; 27(11):1055-9. PubMed ID: 15754738
[TBL] [Abstract][Full Text] [Related]
4. Case report: Complete restoration of the HPA axis function in Cushing's disease with drug treatment.
Nguyen JT; Ferrière A; Tabarin A
Front Endocrinol (Lausanne); 2024; 15():1337741. PubMed ID: 38390203
[TBL] [Abstract][Full Text] [Related]
5. An unusual case of Cushing's syndrome due to bihormonal ACTH-prolactin secreting pituitary macroadenoma with rapid response to cabergoline.
Kunasegaran S; Croxson MS; Holdaway I; Murphy R
BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28784879
[TBL] [Abstract][Full Text] [Related]
6. Concomitant Cushing's Disease and Marked Hyperprolactinemia: Response to a Dopamine Receptor Agonist.
Shiraishi J; Koyama H; Shirakawa M; Ishikura R; Okazaki H; Kurajoh M; Shoji T; Moriwaki Y; Yamamoto T; Namba M
Intern Med; 2016; 55(8):935-41. PubMed ID: 27086808
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
[TBL] [Abstract][Full Text] [Related]
8. Plurihormonal pituitary adenoma cosecreting ACTH and GH: a rare cause of Cushing's disease.
Amir J; Guiot MC; Garfield N
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36410786
[TBL] [Abstract][Full Text] [Related]
9. PPAR-gamma in Cushing's disease.
Heaney AP
Pituitary; 2004; 7(4):265-9. PubMed ID: 16416039
[TBL] [Abstract][Full Text] [Related]
10. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
11. Prolactin correction for adequacy of petrosal sinus cannulation may diminish diagnostic accuracy in Cushing's disease.
De Sousa SMC; McCormack AI; McGrath S; Torpy DJ
Clin Endocrinol (Oxf); 2017 Nov; 87(5):515-522. PubMed ID: 28626863
[TBL] [Abstract][Full Text] [Related]
12. Cabergoline for Cushing's disease: A case report.
Pascual-Corrales E; Tomás Velázquez A; Zubieta JL; Salvador J; Galofré JC
Endocrinol Nutr; 2015 Dec; 62(10):516-8. PubMed ID: 26307390
[No Abstract] [Full Text] [Related]
13. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
Lau D; Rutledge C; Aghi MK
Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
[TBL] [Abstract][Full Text] [Related]
14. Cushing's disease and hyperprolactinemia due to a mixed ACTH- and prolactin-secreting pituitary macroadenoma.
Mahler C; Verhelst J; Klaes R; Trouillas J
Pathol Res Pract; 1991 Jun; 187(5):598-602. PubMed ID: 1656408
[TBL] [Abstract][Full Text] [Related]
15. High prolactin levels in patients with Cushing's disease without pathological evidence of pituitary adenoma.
Comtois R; Beauregard H; Hardy J; Robert F; Somma M
Clin Endocrinol (Oxf); 1993 Jun; 38(6):601-7. PubMed ID: 8392915
[TBL] [Abstract][Full Text] [Related]
16. FSH-producing macroadenoma associated in a patient with Cushing's disease.
Oyama K; Yamada S; Hukuhara N; Hiramatsu R; Taguchi M; Yazawa M; Matsuda A; Ohmura E; Imai Y
Neuro Endocrinol Lett; 2006 Dec; 27(6):733-6. PubMed ID: 17187002
[TBL] [Abstract][Full Text] [Related]
17. Maximizing the accuracy of Inferior petrosal sinus sampling: validation of the use of Prolactin as a marker of pituitary venous effluent in the diagnosis of Cushing's disease.
Grant P; Dworakowska D; Carroll P
Clin Endocrinol (Oxf); 2012 Apr; 76(4):555-9. PubMed ID: 22017348
[TBL] [Abstract][Full Text] [Related]
18. Medical approach to pituitary tumors.
Neggers SJ; van der Lely AJ
Handb Clin Neurol; 2014; 124():303-16. PubMed ID: 25248595
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin and somatostatin receptors in Cushing's disease.
Hofland LJ
Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
[TBL] [Abstract][Full Text] [Related]
20. Desmopressin test in the diagnosis and follow-up of cyclical Cushing's disease.
Leal-Cerro A; Martín-Rodríguez JF; Ibáñez-Costa A; Madrazo-Atutxa A; Venegas-Moreno E; León-Justel A; García-Hernández N; Luque RM; Castaño JP; Cano DA; Soto-Moreno A
Endocrinol Nutr; 2014 Feb; 61(2):69-76. PubMed ID: 24183946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
